Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$36,928,549
-$2,386,194 QoQ
Shares Held
292,295
+3.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#249
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. GILD ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,928,549 | 292,295 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $39,314,743 | 282,089 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,792,530 | 275,318 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $21,370,830 | 192,530 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,895,017 | 170,425 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,028,712 | 178,748 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $22,172,677 | 240,042 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $21,358,825 | 254,757 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,211,700 | 265,438 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,352,823 | 195,943 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,841,846 | 257,275 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,179,916 | 282,625 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,893,106 | 413,820 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $22,588,499 | 272,249 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $21,617,629 | 251,807 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,372,266 | 297,816 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $18,720,083 | 302,865 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $26,657,912 | 448,409 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,350,528 | 431,766 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $43,429,516 | 621,754 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $43,691,461 | 634,497 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $41,060,472 | 635,316 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $34,553,247 | 593,087 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $39,622,024 | 627,030 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $44,929,265 | 583,952 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $35,098,922 | 469,488 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||